SLCO1A2 and hypertensive disorder: Several genes (CCK, SLCO1A2, UGGT2) were identified as targets of drugs (diazoxide, nadolol, hydrochlorothiazide) used to treat hypertension, suggesting opportunities for drug repositioning and risk factor prevention.